If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Trading Update

30 May 2019 12:35

RNS Number : 6357A
Chamberlin PLC
30 May 2019
 

AIM: CMH

30 May 2019

 

 

CHAMBERLIN PLC

("Chamberlin" or "the Group")

 

Trading Update

 

Chamberlin, the specialist castings and engineering group, announced on 5 February 2019 that while the Company's trading position had been strengthened by the sale of Exidor Limited in December 2018, current trading conditions had toughened giving rise to an expected operating loss from continuing operations, before non-underlying items*, in the year to 31 March 2019 of approximately £0.6m.

 

The Company is in the process of finalising the results for the year to 31 March 2019 and following a final review with its auditors the Company now expects to report an operating loss before non-underlying items* some £0.3m worse than previously indicated, mainly reflecting a specific bad debt.

 

The Company had also announced previously that the Board has implemented a number of cost reduction measures, which has involved various reorganisation and other costs necessary in rationalising the business. This exercise has included an impairment review of the two sites within the foundry division, which has resulted in a non-cash write-down in value of the assets of approximately £3.0m.

 

Including this write-down and other non-underlying costs incurred in the period the Company expects to announce an operating loss for the year to 31 March 2019 of approximately £4.5m, together with a profit on discontinued operations of approximately £6.4m, giving rise to a profit after tax and finance costs for the year of approximately £1.5m.

 

The Board expects to issue its preliminary results statement for the year to 31 March 2019 on 4 June 2019.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

* non-underlying costs comprise exceptional items, administration costs of the company pension scheme and net financing costs on pension obligations, share based payment costs, GMP Equalisation, impairment of fixed assets and onerous leases

 

 

Enquiries

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

T: 01922 707100

 

Cenkos Securities plc

(Nominated Adviser and Broker)

Russell Cook, Katy Birkin

T: 020 7397 8900

KTZ Communications

(Financial PR)

Katie Tzouliadis, Dan Mahoney

 

T: 020 3178 6378

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTWGUWWAUPBGGU
Date   Source Headline
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSHolding(s) in Company
18th Feb 202210:30 amRNSResult of General Meeting and Total Voting Rights
2nd Feb 20227:00 amRNSProposed Placing and Subscription and Notice of GM
5th Jan 202212:15 pmRNSResult of AGM
4th Jan 20227:00 amRNSContract Award
21st Dec 20217:00 amRNSHalf-year Report
30th Nov 202111:01 amRNSFinal Results
16th Sep 20217:00 amRNSPublication of Audited Accounts and Trading Update
30th Jul 20217:00 amRNSHolding(s) in Company
9th Jul 20217:00 amRNSOperational Update
8th Jul 20217:00 amRNSHolding(s) in Company
8th Jun 20212:45 pmRNSResult of AGM
1st Jun 20217:00 amRNSDirectorate Change
28th May 20218:00 amRNSDirectorate Change
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
19th May 20219:05 amRNSSecond Price Monitoring Extn
19th May 20219:00 amRNSPrice Monitoring Extension
19th May 20217:00 amRNSOperational Update
14th May 20212:15 pmRNSChange of Accounting Reference Date
14th May 20217:00 amRNSGrant of Options
11th May 20214:41 pmRNSSecond Price Monitoring Extn
11th May 20214:36 pmRNSPrice Monitoring Extension
11th May 20212:05 pmRNSSecond Price Monitoring Extn
11th May 20212:00 pmRNSPrice Monitoring Extension
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
7th May 20217:00 amRNSDirectorate Change
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
27th Apr 20217:00 amRNSDirectorate Change
20th Apr 20214:10 pmEQSHardman & Co Research: Chamberlin (CMH): Getting back into shape
16th Apr 20217:30 amRNSRestoration - Chamberlin Plc
16th Apr 20217:00 amRNSHalf-year Report
16th Apr 20217:00 amRNSFinal Results
13th Apr 20215:04 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFurther re Publication of Accounts
1st Apr 20217:00 amRNSTotal Voting Rights
30th Mar 20215:55 pmRNSHolding(s) in Company
30th Mar 20214:03 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSPlacing, Subscription and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.